Claims for Patent: RE46363

Summary for Patent: RE46363

Title:	Dial-down mechanism for wind-up pen
Abstract:	The present invention relates to a dial-down mechanism for an injection device comprising a torsion spring for assisting injection of a dose of medicament from the injection device, the dial-down mechanism comprising dial-up cam arranged to receive and engage with a dial-up key, wherein the dial-up cam and the dial-up key are adapted to, upon rotation of a dose setting member in a first direction, cooperate to strain the torsion spring of the injection device, and a dial-down cam arranged to receive and engage with a dial-down key, wherein the dial-down cam and the dial-down key are adapted to, upon rotation of the dose setting member in a second direction, cooperate to release the torsion spring of the injection device, the second rotation direction being opposite to the first rotation direction.
Inventor(s):	Moeller Claus Schmidt, Enggaard Christian Peter, Radmer Bo, Markussen Tom Hede
Assignee:	Novo Nordisk A/S
Application Number:	US14091774
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent RE46363
Patent Claims:

Details for Patent RE46363

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	June 16, 2005		2033-11-27
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	October 31, 2013		2033-11-27
Novo Nordisk Inc.	NOVOLOG MIX 50/50	insulin aspart protamine and insulin aspart	Injectable Suspension	021810	August 26, 2008		2033-11-27
Seqirus Inc.	FLUAD	influenza vaccine, adjuvanted	Injection	125510	November 24, 2015		2033-11-27

International Patent Family for US Patent RE46363

Country	Patent Number	Estimated Expiration
South Africa	200703707
World Intellectual Property Organization (WIPO)	2006045526
United States of America	7686786
United States of America	2008147005